How should mobile medical apps be regulated by the FDA?

Last year the FDA released a proposed set of guidelines for the regulation of certain mobile health apps that control a regulated medical device, or manipulate patient data from a medical device. This has been a source of some controversy and anxiety for many medical app developers.

Some argue that too strict regulation may stifle innovation, while others argue it is crucial for ensuring quality apps and protecting patients.

This upcoming Wednesday, June 6, at 9pm EST please join us for a special edition of the #mHealth chat on Twitter, in which we will discuss the FDA regulations and medical app development. Also participating will be our special guest, Mr. M. Jason Brooke, J.D., an experienced attorney on FDA regulations and policy.

Mr. M. Jason Brooke works for the firm Epstein Becker Green in Washington D.C. An associate in the Healthcare and Life Sciences practice, he develops policy on the FDA regulation of mobile health technology and counsels mobile health companies on FDA  regulations. Mr. Brooke also has an extensive scientific research background and advises drug and device developers on clinical research.

You can follow him on Twitter at @MJasonBrooke.

We invite you to participate in this exciting discussion! Come share your opinions, concerns, and questions about this important topic that will affect the entire mobile medical industry.